Dividend-adjusted total return · S&P 500 uses VOO · Oct 7, 2026 – Nov 5, 2026BMEDS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −3.4% | +6.1% | +13.2% | +19.2% | +28.3% | +74.3% | +21.8% | +43.1% |
| Peer average | −5.0% | −7.8% | −6.0% | +4.0% | +3.8% | +81.0% | +11.0% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $15M
- Expense ratio
- 0.77%
- Distribution yield
- 0.2%
- NAV
- $37.28
- Volume
- 10K
- Avg. volume 30D
- 3K
- High today
- $37.40
- Low today
- $36.03
- Previous close
- $37.30
- 52-week high
- $37.40
- 52-week low
- $27.25
- Our risk indicator
- 4/5
BMED in One Breath
BMED Among Disruptive Tech ETFs
YTDEnd-of-day Nov 6, 2026 · 25 Disruptive tech ETFs by YTD
$10,000 in BMED
5Y$10,000 in BMED became
$12,179
In the S&P 500 (VOO)
$17,156
Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO
BMED’s Top Holdings
TodayMRNAModerna6.0%GILD5.9%DHR5.1%ABBV4.8%TMO4.3%BIIB3.7%MTD3.5%IQV3.4%VRTX3.3%EW3.2%MRK3.0%ROP.SW2.8%GMAB2.7%AMGN2.6%A2.3%DXCM2.3%WAT2.2%HALO2.2%ARGX1.7%NBIX1.5%PFE1.5%35 more
Drug Manufacturers - GeneralBiotechnologyMedical - DiagnosticsMedical - Devices
iShares BMED · 57 holdings · tile size = share of the fund · as of Nov 5, 2026
What BMED Holds
TodayDrug Manufacturers - General28.0%
GILD 5.9 · ABBV 4.8 · BIIB 3.7 · MRK 3.0 · ROP.SW 2.8 · AMGN 2.6 · PFE 1.5
Biotechnology27.3%
MRNA 6.0 · VRTX 3.3 · GMAB 2.7 · HALO 2.2 · ARGX 1.7 · NBIX 1.5 · ROIV 1.3
Medical - Diagnostics & Research25.2%
DHR 5.1 · TMO 4.3 · MTD 3.5 · IQV 3.4 · A 2.3 · WAT 2.2 · ILMN 1.5
Medical - Devices7.5%
EW 3.2 · DXCM 2.3 · ABT 1.4 · BRKR
Drug Manufacturers - Specialty & Generic4.6%
GALD.SW 1.4 · TEVA 1.4 · MRK.DE 1.2 · ALKS
Medical - Distribution1.0%
COR
Medical - Healthcare Information Services0.9%
TEM
iShares BMED · share of the fund by industry · as of Nov 5, 2026
Moderna’s Share of BMED
Today6.0%
$60 of every $1,000 in BMED is Moderna
Moderna held by BMED
$899K
iShares BMED · each square = $10 of $1,000 · as of Nov 5, 2026
BMED’s Share of Disruptive Tech ETFs
Today0.0%
of the $50.6B in 26 Disruptive tech ETFs
$14.9M0.0%
$13.0B25.6%
$11.6B22.9%
$26.0B51.4%
Disruptive tech ETF AUM · Nov 6, 2026
BMED Fee per $100 vs Peers
TodayExpense ratio · Disruptive tech peers · Nov 6, 2026
Inside BMED
57 holdings · as of Nov 5, 2026BMED
iShares Health Innovation Active ETF
TodayDrug Manufacturers - General28.0%GILD5.9%ABBV4.8%BIIB3.7%MRK3.0%ROP.SW2.8%AMGN2.6%PFEBMYNOVN.SJNJBiotechnology27.3%MRNA6.0%VRTX3.3%GMAB2.7%HALO2.2%ARGXNBIXROIVCYTKBMRNPTGXUCB.BRAXSM8 moreMedical - Diagnostics25.2%DHR5.1%TMO4.3%MTD3.5%IQV3.4%A2.3%WATILMNCRLGHMedical - Devices7.5%EWDXCM2.3%ABTBRKRDrug Manufacturers - Specialty4.6%GALD.STEVAMRK.DCORTEMOther5.4%
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 6.03% |
| 2 | GILD | Gilead Sciences | 5.90% |
| 3 | DHR | Danaher | 5.10% |
| 4 | ABBV | Abbvie | 4.81% |
| 5 | TMO | Thermo Fisher Scientific | 4.28% |
| 6 | BIIB | Biogen | 3.67% |
| 7 | MTD | Mettler Toledo | 3.52% |
| 8 | IQV | Iqvia | 3.41% |
| 9 | VRTX | Vertex Pharmaceuticals | 3.26% |
| 10 | EW | Edwards Lifesciences | 3.16% |
Drug Manufacturers - GeneralBiotechnologyMedical - DiagnosticsMedical - DevicesDrug Manufacturers - SpecialtyMedical - DistributionMedical - Healthcare Information ServicesOther
iShares BMED · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 66.5%
All BMED Holdings
61 holdings · as of Nov 5, 2026BMED
BMED’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 6.03% | $603.01 | 3,476 | $898K |
| 2 | GILDGilead Sciences | Healthcare | 5.90% | $589.60 | 5,033 | $878K |
| 3 | —BLK CSH FND Treasury SL Agency | — | 5.24% | $523.69 | 780K | $780K |
| 4 | DHRDanaher | Healthcare | 5.10% | $509.79 | 3,232 | $759K |
| 5 | ABBVAbbvie | Healthcare | 4.81% | $481.22 | 2,431 | $717K |
| 6 | TMOThermo Fisher Scientific | Healthcare | 4.28% | $427.65 | 902 | $637K |
| 7 | BIIBBiogen | Healthcare | 3.67% | $367.32 | 2,150 | $547K |
| 8 | MTDMettler Toledo | Healthcare | 3.52% | $351.72 | 304 | $524K |
| 9 | IQVIqvia | Healthcare | 3.41% | $340.58 | 1,923 | $507K |
| 10 | VRTXVertex Pharmaceuticals | Healthcare | 3.26% | $325.87 | 884 | $485K |
| 11 | EWEdwards Lifesciences | Healthcare | 3.16% | $315.97 | 4,736 | $471K |
| 12 | MRKMerck | Healthcare | 2.97% | $297.10 | 2,943 | $443K |
| 13 | ROP.SWRoche PS PAR AG | Healthcare | 2.77% | $277.47 | 853 | $413K |
| 14 | GMABGenmab Sponsored | Healthcare | 2.68% | $267.60 | 7,231 | $399K |
| 15 | AMGNAmgen | Healthcare | 2.58% | $257.64 | 802 | $384K |
iShares BMED · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 5, 2026
How It Compares
BMED
iShares Health Innovation Active ETF’s Peers
YTDDisruptive tech peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put BMED head to head with IGV →IGV vs BMED
YTDYear to date
BMED wins+25.5 pts
Past year
BMED wins+39.9 pts
Fee
IGV winslower fee
Yield
BMED wins+0.2 pts
AUM
IGV870.6× more
3–1BMED wins
iShares IGV and iShares BMED · year-to-date · as of Nov 6, 2026 · AUM not scored
Disruptive Tech vs Thematic
Average · YTDIGV
−6.3%
BMED
+19.2%
Thematic average
+2.3%
IGV, BMED and the average thematic ETF · YTD return · as of Nov 6, 2026
BMED vs VOO
YTDBMED · iShares Health Innovation Active
+19.2%
VOO · S&P 500
+8.4%
Gap
10.8 pts
iShares BMED and Vanguard VOO · YTD total return · as of Nov 6, 2026
BMED vs Its Peer Average
YTDBMEDAvsBPeer average
1D−3.4%−5.0%
1M+6.1%−7.8%
3M+13.2%−6.0%
YTD+19.2%+4.0%
1Y+28.3%+3.8%
3Y+74.3%+81.0%
5Y+21.8%+11.0%
6–1BMED wins
25 Disruptive tech peers · each row scaled to its leader
The Details
BMED
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y18.26%
Deepest drop · 1Y−14.9%
Lowest point · 5Y−30.1%
52-week range
$36.05
$27.25−3.6% from the high$37.40
iShares BMED · past-year price moves · as of Nov 6, 2026
BMED
Fund Facts
Today2020launched Sep 29
Tracks[…]
Exchange · CUSIPAMEX · 09290C400
StructureETF
Leverage1x
Cost on $10,000$77 a year
Go deeper
iShares BMED · fund facts · as of Nov 6, 2026
BMED
Payouts by Year
2Y$0.0812per share, Jun 2026
Distribution yield0.2%
Paid[…]
Latest ex-date · paidJun 15 · Jun 18, 2026
2 payouts added up$0.0884 a share
iShares BMED · distributions by ex-date · 2023–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Trading & Liquidity
Net asset value$37.28
Premium / discount[…]
Median spread · 30D[…]
Volume today10K
Average volume · 30D3K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.77%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$77.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $0.0812 |
| Dec 20, 2023 | Dec 27, 2023 | $0.0072 |
Issuer contentFrom iSharesHear the strategy from the people behind BMED.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →